{"gene":"RGS9","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":1998,"finding":"RGS9 was identified as the GTPase-accelerating protein (GAP) for the visual G protein transducin (Gαt) in rod outer segments; its RGS domain accelerates GTP hydrolysis by Gαt, and this activity is enhanced by the PDEγ subunit of cGMP phosphodiesterase.","method":"In vitro GTPase assay, mRNA expression analysis, protein colocalization to photoreceptor outer segments","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro GAP activity, multiple orthogonal methods, foundational paper with >295 citations","pmids":["9459445"],"is_preprint":false},{"year":1998,"finding":"RGS9 directly interacts with retinal guanylyl cyclase (retGC) and inhibits its activity, suggesting RGS9 mediates a direct link between the cGMP-phosphodiesterase and guanylyl cyclase systems in phototransduction.","method":"2D gel electrophoresis, antibody binding assay, immunoprecipitation, in vitro GC activity assay, peptide sequencing","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — direct interaction shown by IP and overlay, single lab with multiple methods","pmids":["9712827"],"is_preprint":false},{"year":1999,"finding":"Functionally active RGS9 in vertebrate photoreceptors exists as a tight complex with the long splice variant of Gβ5 (Gβ5L); this complex forms when RGS9 and Gβ5L are co-expressed in cell culture, and the GGL domain of RGS9 mediates the Gβ5 interaction.","method":"Co-purification from native photoreceptors, co-expression in cell culture, biochemical characterization","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 — native complex purification plus cell culture reconstitution, replicated across labs","pmids":["10051575"],"is_preprint":false},{"year":1999,"finding":"RGS9-2, a striatum-specific splice isoform of RGS9 with a unique 191-amino-acid C-terminal extension, dampens Gi/o-coupled mu-opioid receptor response in vitro, while the retinal isoform RGS9-1 does not.","method":"Cloning from forebrain cDNA library, in vitro functional assay with mu-opioid receptor, immunohistochemistry","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — functional isoform comparison with direct in vitro assay, independent characterization","pmids":["10066255"],"is_preprint":false},{"year":1999,"finding":"The PDEγ C-terminal domain (residues 63–87) potentiates RGS9 GAP activity toward Gαt; chimeric RGS9/RGS16 analysis mapped the structural determinants to the α3–α5 region of the RGS9 domain, which faces the PDEγ binding site on Gαt.","method":"In vitro GTPase assay, chimeric protein mutagenesis, structure-function analysis","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro with mutagenesis, mechanistic domain mapping","pmids":["10213594"],"is_preprint":false},{"year":2000,"finding":"RGS9-1 knockout mice lack functional Gβ5L protein (despite normal mRNA) and exhibit severely slowed GTP hydrolysis in rod outer segment membranes and dramatically prolonged photoresponse recovery, establishing RGS9-1/Gβ5L as essential for transducin GTPase acceleration in vivo.","method":"Mouse knockout, ROS GTPase assay, electrophysiology (single-cell recordings), Western blot","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1–2 — knockout mouse with in vitro GTPase assay and electrophysiology, replicated and foundational","pmids":["10676965"],"is_preprint":false},{"year":2000,"finding":"Gβ5L stabilizes RGS9-1 protein and is required for its folding and GAP activity; the GGL-Gβ5 complex modulates GAP activity in response to PDEγ; the C-terminal domain of RGS9-1 contributes to effector stimulation. Native Gβ5 and R7-family RGS proteins exist exclusively as obligate heterodimers in cells, maintained by mutual protein stabilization (non-transcriptional mechanism).","method":"In vitro reconstitution, domain deletion mutagenesis, transgenic Xenopus, co-purification, immunoprecipitation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with mutagenesis, confirmed in vivo in transgenic Xenopus","pmids":["10978345","10840031"],"is_preprint":false},{"year":2001,"finding":"RGS9-1 is phosphorylated by an endogenous protein kinase at Ser475 in rod outer segments in a light- and Ca2+-dependent manner; phosphorylation at this site reduces RGS9-1 GAP activity, identified as a potential mechanism for light-adaptation feedback on phototransduction.","method":"32P-ATP labeling, mass spectrometry, site-directed mutagenesis (S475A), in vitro kinase assay, immunoblot of dark- vs. light-adapted retina","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — phosphosite identified by MS, mutagenesis confirmed, activity assay, in vivo light-regulation shown","pmids":["11292825"],"is_preprint":false},{"year":2001,"finding":"PKA is the major kinase responsible for RGS9-1 phosphorylation in rod outer segments; phosphorylation sites mapped to Ser427 and Ser428; phosphomimetic substitution (Ser→Glu) reduces GAP activity.","method":"Kinase inhibitor panel, dibutyryl-cAMP stimulation, recombinant PKA phosphorylation, mutagenesis, in vitro GAP assay","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro phosphorylation with mutagenesis and functional readout","pmids":["11601986"],"is_preprint":false},{"year":2001,"finding":"RGS9-1 is required for normal inactivation of both rod and cone phototransduction; cones of RGS9-1−/− mice show ~60-fold slower recovery after bright conditioning flash.","method":"ERG in knockout mice, immunohistochemistry","journal":"Molecular vision","confidence":"High","confidence_rationale":"Tier 2 — knockout with defined electrophysiological phenotype replicated in cone and rod pathways","pmids":["11262419"],"is_preprint":false},{"year":2001,"finding":"The C-terminal domain of RGS9-1 (absent in RGS9-2) is critical for tight membrane binding to rod outer segment disk membranes; Gβ5L does not itself play an important role in membrane attachment.","method":"Limited proteolysis, recombinant domain constructs, membrane binding assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — domain deletion with direct membrane binding quantification","pmids":["11677233"],"is_preprint":false},{"year":2001,"finding":"Gβ5 and R7-family RGS proteins (including RGS9) always co-exist as obligate heterodimers in native tissue; Gβ5 co-expression dramatically increases RGS protein levels via protein stabilization, not transcriptional effects.","method":"Immunoprecipitation, conventional chromatography, co-expression in COS-7 cells, Western blot","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple biochemical approaches across native tissue and cell lines","pmids":["10840031"],"is_preprint":false},{"year":2001,"finding":"Noncatalytic domains of RGS9-1·Gβ5 play a decisive role in establishing substrate specificity for transducin bound to its effector (PDE) rather than free transducin; double L353E/R360P mutation reversed specificity of the catalytic domain alone but not of the full complex.","method":"Site-directed mutagenesis, single-turnover GTPase assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis with reconstituted in vitro functional assay","pmids":["11495924"],"is_preprint":false},{"year":2002,"finding":"R9AP (RGS9-1 Anchor Protein) is a 25-kDa transmembrane phosphoprotein that binds to the N-terminal domain of RGS9-1 via its DEP domain and anchors RGS9-1·Gβ5 to photoreceptor disk membranes via a C-terminal transmembrane helix; R9AP is expressed exclusively in photoreceptors.","method":"Co-immunoprecipitation from detergent extracts, cDNA cloning, immunohistochemistry, domain binding assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — co-IP of endogenous complex plus domain mapping, replicated","pmids":["12119397"],"is_preprint":false},{"year":2002,"finding":"Specific binding of RGS9-1·Gβ5L to R9AP-containing photoreceptor membranes (via the DEP domain) produces an ~70-fold increase in RGS9-1 catalytic activity toward transducin GTPase; membrane association is DEP-domain dependent.","method":"Urea extraction, recombinant protein binding to native membranes, in vitro GTPase assay, domain deletion constructs","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted membrane binding with domain mutagenesis and enzymatic assay","pmids":["12006596"],"is_preprint":false},{"year":2002,"finding":"Light exposure triggers translocation of the RGS9-1·Gβ5L complex (along with transducin) to detergent-resistant membrane rafts; this translocation requires Gαt activation (blocked by GTPγS or pertussis toxin, mimicked by AlF4−); phosphorylation of RGS9-1 occurs exclusively within rafts.","method":"Detergent-resistant membrane fractionation, light/dark adaptation experiments, pharmacological manipulation of G-protein state","journal":"Current biology : CB","confidence":"Medium","confidence_rationale":"Tier 2 — multiple pharmacological controls demonstrating G-protein state dependence, single lab","pmids":["11882295"],"is_preprint":false},{"year":2002,"finding":"PKCα and PKCθ are the major kinases responsible for RGS9-1 phosphorylation at Ser475 in rod outer segments; phosphorylation is removed by protein phosphatase 2A; PKC-mediated phosphorylation reduces RGS9-1 affinity for R9AP.","method":"Kinase purification, in vitro kinase assay with recombinant PKC isoforms, synthetic peptide substrate, protein phosphatase assay, affinity assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — purification of kinase activity, reconstituted phosphorylation, functional consequence on R9AP binding","pmids":["12499365"],"is_preprint":false},{"year":2002,"finding":"The N-terminus of RGS9-1 directly inhibits retinal guanylyl cyclase (retGC) activity; the GGL and RGS domains serve as internal suppressors of this inhibitory activity; direct interaction of retGC with RGS9-1 N-terminus confirmed by immunoprecipitation and overlay.","method":"Immunoprecipitation, overlay assay, in vitro retGC activity assay with RGS9-1 fragments","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding and enzymatic assay, single lab","pmids":["11485301"],"is_preprint":false},{"year":2003,"finding":"RGS9-2 modulates dopamine D2 receptor function in striatum; viral overexpression of RGS9-2 in nucleus accumbens reduced locomotor responses to cocaine and D2 agonists; RGS9 knockout mice showed heightened locomotor and rewarding responses to cocaine; in Xenopus oocytes, RGS9-2 accelerated off-kinetics of D2R-induced GIRK currents.","method":"Viral-mediated overexpression, knockout mouse behavioral assays, Xenopus oocyte electrophysiology (GIRK currents)","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (in vivo overexpression, knockout behavior, electrophysiology), replicated across labs","pmids":["12818179"],"is_preprint":false},{"year":2003,"finding":"R9AP knockout results in complete absence of RGS9 protein (not mRNA) from retina, establishing that R9AP determines the proteolytic stability of the RGS9·Gβ5 complex; all three proteins (RGS9, Gβ5, R9AP) are obligate members of the photoreceptor GAP complex.","method":"R9AP knockout mouse, Western blot, mRNA analysis, electrophysiology","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — knockout mouse with protein/mRNA dissociation and functional readout","pmids":["14625292"],"is_preprint":false},{"year":2003,"finding":"The DEP domain of RGS9 is essential for its delivery to rod outer segments; transgenic mice expressing DEP-domain-deleted RGS9 show normal expression levels but complete exclusion from outer segments; the DEP domain mediates interaction with R9AP which both targets RGS9 to outer segments and potentiates its catalytic activity.","method":"Transgenic mouse (DEP-deleted RGS9), quantitative serial tangential sectioning-Western blot, electrophysiology, domain interaction assays","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 — transgenic mouse with quantitative localization and electrophysiological readout","pmids":["14614075"],"is_preprint":false},{"year":2003,"finding":"Gbeta5/RGS9 and other Gbeta5/R7 dimers are selective GAPs for Gi-family Gα subunits (not Gαq or Gα11); Gbeta5/RGS9 and Gbeta5/RGS11 are more potent GAPs for Gαi1, Gαi2, and Gαi3 than Gbeta5/RGS6 or Gbeta5/RGS7.","method":"Purified Sf9-expressed proteins, steady-state GTPase assay in proteoliposomes with M1/M2 muscarinic receptors","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — purified proteins in reconstituted lipid system with quantitative kinetics","pmids":["12531899"],"is_preprint":false},{"year":2003,"finding":"RGS9-2 via its DEP domain colocalizes with D2 dopamine receptors in mammalian cells; RGS9-2 DEP domain preferentially accelerates termination of D2 receptor (not M2 muscarinic) signals in oocytes; RGS9 knockout mice develop abnormal involuntary movements when D2 signaling is activated after dopaminergic inhibition, and RGS9-2 deletion abnormally inhibits glutamate-elicited currents in striatal neurons.","method":"Colocalization in transfected mammalian cells, oocyte electrophysiology, mouse knockout, striatal neuron recordings, behavioral analysis","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods across cell, slice, and in vivo preparations","pmids":["15728856"],"is_preprint":false},{"year":2003,"finding":"RGS9 (as RGS9-2) is essential for normal opiate action; mice lacking RGS9 show enhanced responses to acute and chronic morphine; acute morphine increases RGS9-2 in NAc while chronic exposure decreases it, showing reciprocal regulation.","method":"Knockout mouse behavioral assays (analgesia, reward, dependence/withdrawal), Western blot","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — knockout with defined behavioral phenotypes across multiple paradigms","pmids":["14595021"],"is_preprint":false},{"year":2003,"finding":"R9AP binding site on RGS9-1 is in the N-terminal (DEP-containing) domain; R9AP reconstituted into lipid vesicles increases RGS9-1 GAP activity 4-fold; the DEP domain is required for high-affinity binding (Kd <10 nM) to R9AP vesicles.","method":"Recombinant protein purification, lipid vesicle reconstitution, binding affinity measurements, single-turnover GTPase assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — purified proteins, reconstituted lipid system, quantitative binding and catalytic assays","pmids":["12560335"],"is_preprint":false},{"year":2004,"finding":"Mutations in RGS9 or R9AP in humans cause bradyopsia (delayed photoreceptor deactivation with difficulty adapting to luminance changes); R9AP enhances RGS9 activity up to 70-fold and anchors it to photoreceptor membranes.","method":"Human genetic analysis (sequencing), clinical electrophysiology, phenotype characterization","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — human loss-of-function mutations with defined visual phenotype, confirmed mechanism","pmids":["14702087"],"is_preprint":false},{"year":2004,"finding":"RGS9-2 specifically modulates D2 dopamine receptor (not M2 muscarinic receptor) inhibition of Cav2.2 calcium channels in striatal cholinergic interneurons; dialysis with RGS9 constructs enhanced basal Ca2+ channel currents; the DEP-GGL domain antagonizes endogenous RGS9-2 activity.","method":"Whole-cell patch clamp in striatal neurons, intracellular dialysis with RGS9 constructs, in vitro GTPase assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — direct intraneuronal protein delivery with receptor-selective electrophysiological readout","pmids":["15534226"],"is_preprint":false},{"year":2004,"finding":"The brain-specific unique polyproline-rich C-terminus of RGS9-2 contains sequences sufficient to target RGS9-2 to the nucleus of COS-7 cells and striatal neurons; Gβ5 further enhances nuclear localization of RGS9-2 (but not RGS9-1); nuclear RGS9-2 increases transcriptional activity of a neuronal gene construct.","method":"Immunocytochemistry, immunoblot fractionation, deletion construct transfection, reporter gene assay","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 3 — localization by transfection with deletion constructs, single lab, transcriptional effect not fully mechanistic","pmids":["15110994"],"is_preprint":false},{"year":2005,"finding":"Mu-opioid receptor (MOR) activation promotes transfer of Gα subunits from MOR to RGS9-2 complexes, followed by Ser phosphorylation of RGS9-2 and its association with 14-3-3 proteins; tolerance-inducing morphine doses stabilize Gα retention by RGS9-2; knockdown of RGS9-2 prevents this transfer and blocks tolerance.","method":"Co-immunoprecipitation from periaqueductal gray membranes, in vivo antisense knockdown, [35S]GTPγS binding, GTPase assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP plus knockdown with functional readout, single lab","pmids":["15632124"],"is_preprint":false},{"year":2006,"finding":"R7BP controls the proteolytic stability of RGS9-2: co-expression with R7BP dramatically elevates RGS9-2 and Gβ5 protein levels by reducing constitutive proteolysis; R7BP binds RGS9 via an interface formed by the DEP domain paired with the R7H domain; lentiviral R7BP knockdown in native striatal neurons reduces RGS9-2 protein.","method":"Co-expression in cells, protein degradation kinetics, site-directed mutagenesis of binding interface, lentiviral RNAi in striatal neurons, Western blot","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple methods (degradation kinetics, mutagenesis, native neuron RNAi), consistent results","pmids":["17158100"],"is_preprint":false},{"year":2006,"finding":"Subcellular targeting of RGS9-2 to plasma membrane and postsynaptic densities in striatal neurons requires the C-terminal 21 amino acids of R7BP, specifically the synergistic action of a polybasic motif and palmitoylated cysteines; depalmitoylation of R7BP unmasks nuclear localization sequences enabling nuclear import.","method":"Subcellular fractionation, site-directed mutagenesis of R7BP C-terminus, live-cell imaging, postsynaptic density fractionation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — mutagenesis combined with fractionation in native neurons","pmids":["16574655"],"is_preprint":false},{"year":2006,"finding":"R9AP potentiation of RGS9-1 GAP activity is a direct increase in catalytic activity (not simply enhanced G-protein binding); the N-terminal trihelical domain of R9AP contains the RGS9-1 binding site, but the entire R9AP molecule is required for potentiation.","method":"Kinetic GTPase assay, R9AP domain deletion constructs, binding assays","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — mechanistic kinetic dissection with domain constructs in reconstituted system","pmids":["16939221"],"is_preprint":false},{"year":2007,"finding":"RGS9-2 constitutive degradation is mediated by lysosomal cysteine proteases; R7BP binding to RGS9-2 shields degradation determinants and controls RGS9-2 expression at the posttranslational level; R7BP also targets RGS9-2 to postsynaptic densities in neurons.","method":"Protease inhibitor studies, co-expression with R7BP, Western blot quantification, immunohistochemistry in developing striatum","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — mechanistic identification of protease class and protective partner, multiple methods","pmids":["18094251"],"is_preprint":false},{"year":2007,"finding":"Striatal RGS9-2 overexpression (via viral vector) in MPTP-lesioned monkeys and 6-OHDA-lesioned rats reduces L-DOPA-induced involuntary movements without reducing anti-parkinsonian effects of L-DOPA; RGS9 knockout mice are more susceptible to L-DOPA-induced dyskinesia, establishing RGS9-2 as a negative modulator of dyskinesia.","method":"Viral vector overexpression in primates and rats, RGS9 knockout mice, behavioral scoring","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — gain- and loss-of-function in multiple species with defined behavioral outcomes","pmids":["18160641"],"is_preprint":false},{"year":2008,"finding":"Crystal structure of the Gβ5-RGS9 complex at 1.95 Å resolution reveals a canonical RGS domain functionally integrated within a molecular complex poised for coordination of multiple G-protein activation and deactivation steps.","method":"X-ray crystallography","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure of native functional complex","pmids":["18204463"],"is_preprint":false},{"year":2008,"finding":"RGS9-2 can functionally replace RGS9-1 in rod photoreceptors and supports normal photoresponse recovery; RGS9-2 inactivates transducin regardless of its effector interactions (G protein-effector complex-independent), whereas RGS9-1 preferentially acts on the G protein–effector complex.","method":"Transgenic mouse replacement of RGS9-1 with RGS9-2, single-cell electrophysiology, ERG","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — functional isoform swap in living cells with electrophysiological characterization","pmids":["19098104"],"is_preprint":false},{"year":2010,"finding":"RGS9-2 inhibits dopamine-mediated internalization of D2R specifically (not delta opioid receptor); this requires the DEP domain and GTPase-accelerating activity of RGS9-2; RGS4 does not share this specificity.","method":"Transfection of RGS9-2 and mutants in cells, receptor internalization assay, receptor-specific comparison","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 3 — cell-based assay with domain mutants, single lab","pmids":["20477943"],"is_preprint":false},{"year":2010,"finding":"Hsc70 is recruited to the intrinsically disordered C-terminal domain of RGS9-2 following its dissociation from R7BP, mediating RGS9-2 degradation; identified by quantitative in vivo interactome analysis using knockout controls.","method":"Quantitative proteomics with knockout controls, co-immunoprecipitation, Western blot","journal":"Journal of proteome research","confidence":"Medium","confidence_rationale":"Tier 2 — quantitative proteomics with matched knockouts, functional dissection of degradation pathway","pmids":["20095651"],"is_preprint":false},{"year":2011,"finding":"Gβ5 is required for RGS9 to associate with membrane anchors (R7BP or R9AP); the binding interface between the N-terminal lobe of RGS9 and Gβ5 interaction surface is needed for R7BP recruitment; distinct molecular determinants in the DEP/DHEY–Gβ5 interface differentially control R7BP binding vs. proteolytic stabilization.","method":"Protein-protein interaction assays, co-localization, protein stability assays, site-directed mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — systematic mutagenesis with multiple functional readouts","pmids":["21511947"],"is_preprint":false},{"year":2011,"finding":"β-arrestin2 scaffolds interactions among the DEP domain of RGS9-2, Gβ5, R7BP, and D3R; β-arrestin2 competes with R7BP and Gβ5 to place RGS9-2 in an open cytosolic conformation capable of inhibiting GPCR signaling; receptor affinity for β-arrestin2 determines the selectivity of RGS9-2 for a given receptor.","method":"Co-immunoprecipitation, transfection with domain mutants, signaling assays in cells","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP with domain mutants and signaling readouts, single lab","pmids":["22006018"],"is_preprint":false},{"year":2011,"finding":"RGS9-2 in striatum forms distinct Gα-containing complexes depending on the MOR agonist: morphine uniquely promotes RGS9-2/Gαi3 association; RGS9-2/Gαq complexes form with multiple MOR agonists but not morphine; repeated morphine forms RGS9-2/Gβ5/Gαq complexes associated with analgesic tolerance.","method":"Co-immunoprecipitation from striatum, pharmacological manipulation, behavioral assays","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP with multiple agonists revealing agonist-selective complex formation, single lab","pmids":["21490202"],"is_preprint":false},{"year":2012,"finding":"RGS9-2/Gβ5 complex directly interacts with and suppresses basal activity of type 5 adenylyl cyclase (AC5); it also attenuates Gβγ stimulation of AC5 by facilitating Gαo GTPase activity; and accelerates AC5 recovery from Gαi inhibition by increasing Gαi deactivation rate. Mice lacking RGS9 show increased cAMP production and enhanced AC5 sensitization upon opioid withdrawal.","method":"Co-immunoprecipitation, AC5 activity assay, RGS9 knockout mice, cAMP measurements","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 2 — direct binding plus enzymatic assay plus knockout validation, multiple mechanisms established","pmids":["22932702"],"is_preprint":false},{"year":2013,"finding":"RGS9-1 and Gβ5L undergo light-dependent translocation from rod inner segments to outer segments; prolonged dark adaptation causes them to accumulate in inner segments while their anchor R9AP remains in outer segments; RGS9-1 is phosphorylated at S475 in the dark, and dim light exposure leads to rapid de-phosphorylation.","method":"Immunofluorescence, Western blot with phospho-specific antibody, light/dark adaptation protocol","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization experiment with functional consequence (phosphorylation state linked to translocation), single lab","pmids":["23555598"],"is_preprint":false},{"year":2018,"finding":"RGS9-2 ablation in D2-MSNs reduces NMDAR-mediated calcium influx, increases AMPAR/NMDAR ratio, and inhibits retrograde endocannabinoid signaling from D2-MSNs to CB1 receptors on presynaptic terminals, leading to increased mEPSC frequency and altered paired-pulse ratio; effects are selective to D2-MSNs, not D1-MSNs.","method":"Electrophysiology in identified MSN subtypes, calcium imaging, pharmacological dissection, behavioral assays with MK-801/ketamine","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific electrophysiology and pharmacological dissection revealing novel synaptic mechanism","pmids":["30006367"],"is_preprint":false},{"year":2019,"finding":"RGS9-2 in striatum controls D2 receptor protein levels by competing with β-arrestin2 for D2R binding protein interactions, preventing lysosomal degradation of D2R; RGS9-2 depletion mimics D2R loss in DYT1 dystonia, and RGS9-2 overexpression rescues D2R levels and electrophysiological responses in Dyt1 striatal neurons.","method":"Western blot, co-immunoprecipitation, lentiviral overexpression, lysosomal inhibitor experiments, electrophysiology","journal":"EMBO molecular medicine","confidence":"High","confidence_rationale":"Tier 2 — mechanistic dissection with gain- and loss-of-function plus pharmacological validation","pmids":["30552094"],"is_preprint":false}],"current_model":"RGS9 exists as two splice isoforms (RGS9-1 in photoreceptors, RGS9-2 in striatum) that function as GTPase-accelerating proteins for Gα subunits within obligate heterodimeric complexes with Gβ5; RGS9-1·Gβ5 is anchored to photoreceptor disk membranes by R9AP (which enhances catalytic activity ~70-fold via the DEP domain interaction and is required for proteolytic stability), where it accelerates Gαt GTP hydrolysis (potentiated by PDEγ) to enable rapid photoresponse recovery, and is subject to PKC/PKA-mediated phosphorylation at Ser475 in a light/Ca2+-regulated feedback mechanism; RGS9-2·Gβ5 is targeted to the plasma membrane and postsynaptic densities of striatal neurons by palmitoylated R7BP (which also protects RGS9-2 from constitutive lysosomal cysteine protease degradation via Hsc70), where it specifically terminates D2 dopamine receptor and mu-opioid receptor signaling by deactivating Gαi/o subunits and directly suppressing type 5 adenylyl cyclase, thereby regulating locomotion, reward, opiate analgesia/tolerance, and synaptic plasticity through NMDAR-dependent retrograde endocannabinoid signaling in D2-MSNs."},"narrative":{"teleology":[{"year":1998,"claim":"Identification of RGS9 as the photoreceptor GAP for transducin resolved the long-standing question of what accelerates GTP hydrolysis on Gαt during photoresponse recovery, with PDE6γ acting as a co-factor.","evidence":"In vitro GTPase assay with purified RGS9 domain, mRNA expression in rod outer segments","pmids":["9459445"],"confidence":"High","gaps":["Physiological requirement not yet shown in vivo","Mechanism of PDE6γ potentiation structurally unresolved","No information on non-retinal isoforms"]},{"year":1999,"claim":"Discovery that RGS9 exists as an obligate heterodimer with Gβ5L (via the GGL domain) and that a brain-specific isoform RGS9-2 modulates mu-opioid receptor signaling established RGS9 as a multi-isoform, multi-tissue GPCR regulator.","evidence":"Co-purification from native photoreceptors, cloning of RGS9-2 from forebrain cDNA, in vitro mu-opioid receptor functional assay","pmids":["10051575","10066255"],"confidence":"High","gaps":["In vivo requirement for Gβ5 not yet demonstrated","Mechanism of isoform-specific substrate selectivity unclear","Striatal function of RGS9-2 not yet tested in vivo"]},{"year":2000,"claim":"RGS9-1 knockout mice proved that the RGS9-1·Gβ5L complex is essential in vivo for rapid photoresponse recovery and that Gβ5L protein stability depends entirely on RGS9-1 co-expression.","evidence":"Knockout mouse with single-cell electrophysiology and rod outer segment GTPase assay","pmids":["10676965"],"confidence":"High","gaps":["Anchoring mechanism to disk membranes unknown","Contribution to cone recovery not yet quantified","Regulatory mechanisms (phosphorylation, translocation) not addressed"]},{"year":2001,"claim":"Identification of light- and Ca²⁺-dependent phosphorylation at Ser475 (by PKC) and Ser427/428 (by PKA) that reduces GAP activity established a feedback regulatory mechanism linking phototransduction to RGS9-1 catalytic output.","evidence":"Mass spectrometry phosphosite identification, site-directed mutagenesis, recombinant kinase assays, dark/light-adapted retinal comparison","pmids":["11292825","11601986"],"confidence":"High","gaps":["Physiological impact of phosphorylation on photoresponse kinetics not tested in vivo","Phosphatase identity not fully confirmed in situ","Whether phosphorylation affects R9AP binding not yet known"]},{"year":2002,"claim":"Discovery of R9AP as a transmembrane anchor that binds the DEP domain of RGS9-1 and enhances catalytic activity ~70-fold resolved how RGS9 is targeted to disk membranes and why membrane association is required for full GAP function.","evidence":"Co-immunoprecipitation, DEP domain binding assays, reconstitution on R9AP-containing membranes with GTPase kinetics","pmids":["12119397","12006596"],"confidence":"High","gaps":["R9AP role in protein stability not yet demonstrated","Structural basis of R9AP-mediated catalytic potentiation unresolved","Whether an analogous anchor exists for RGS9-2 in brain unknown"]},{"year":2002,"claim":"PKCα/θ-mediated Ser475 phosphorylation was shown to reduce RGS9-1 affinity for R9AP and is reversed by PP2A, linking the phosphorylation feedback to the membrane-anchoring mechanism.","evidence":"Kinase purification, recombinant PKC isoform assay, phosphatase assay, R9AP affinity measurement","pmids":["12499365"],"confidence":"High","gaps":["In vivo consequence of PKC phosphorylation on R9AP binding not tested","Whether translocation from membranes occurs upon phosphorylation unknown"]},{"year":2003,"claim":"RGS9-2 was established as a critical regulator of dopaminergic and opioid signaling in striatum: knockout mice showed enhanced cocaine reward and locomotor responses, enhanced morphine analgesia and tolerance, and dyskinesia upon D2 activation after dopamine depletion.","evidence":"Knockout mouse behavioral assays across cocaine, morphine, and L-DOPA paradigms; viral overexpression in nucleus accumbens; Xenopus oocyte electrophysiology","pmids":["12818179","14595021","15728856"],"confidence":"High","gaps":["Cell-type specificity of RGS9-2 action (D1- vs D2-MSN) not resolved","Downstream signaling effectors in striatum not identified","Whether RGS9-2 acts via GAP activity alone or additional mechanisms unknown"]},{"year":2003,"claim":"R9AP knockout demonstrated that R9AP is absolutely required for RGS9 protein stability (not transcription) in vivo, confirming all three proteins (RGS9, Gβ5, R9AP) as obligate subunits of the photoreceptor GAP complex.","evidence":"R9AP knockout mouse with protein vs. mRNA analysis and electrophysiology","pmids":["14625292"],"confidence":"High","gaps":["Mechanism of proteolytic degradation in absence of R9AP not identified","Whether R9AP controls RGS9 trafficking beyond stability unclear"]},{"year":2004,"claim":"Human loss-of-function mutations in RGS9 (and R9AP) were shown to cause bradyopsia, establishing the first Mendelian disease caused by disruption of the photoreceptor GAP complex.","evidence":"Human genetic sequencing, clinical electrophysiology in affected families","pmids":["14702087"],"confidence":"High","gaps":["Genotype-phenotype correlation across mutation types not established","Whether heterozygous carriers have subclinical phenotypes unknown"]},{"year":2006,"claim":"R7BP was identified as the brain-specific membrane anchor for RGS9-2, controlling both its subcellular targeting to postsynaptic densities (via palmitoylation and a polybasic motif) and proteolytic stability by shielding it from constitutive degradation.","evidence":"Co-expression studies, degradation kinetics, mutagenesis of R7BP C-terminus, lentiviral knockdown in native striatal neurons, subcellular fractionation","pmids":["17158100","16574655"],"confidence":"High","gaps":["Identity of the protease pathway not yet determined","Whether R7BP also modulates RGS9-2 catalytic activity (as R9AP does for RGS9-1) untested"]},{"year":2007,"claim":"The constitutive degradation pathway for RGS9-2 was identified as lysosomal cysteine protease-dependent, with R7BP binding shielding degradation determinants; Hsc70 was later shown to mediate RGS9-2 delivery to the degradation pathway upon R7BP dissociation.","evidence":"Protease inhibitor studies, co-expression with R7BP, quantitative proteomics with knockout controls","pmids":["18094251","20095651"],"confidence":"High","gaps":["Specific cysteine protease identity not determined","Whether Hsc70 delivers RGS9-2 via chaperone-mediated autophagy not confirmed"]},{"year":2008,"claim":"The 1.95 Å crystal structure of the Gβ5–RGS9 complex revealed how the canonical RGS domain is integrated within a multidomain scaffold poised for coordinated G-protein regulation.","evidence":"X-ray crystallography","pmids":["18204463"],"confidence":"High","gaps":["Structure of the full tripartite complex with R9AP or R7BP not determined","Structural basis of PDE6γ potentiation unresolved"]},{"year":2012,"claim":"RGS9-2·Gβ5 was shown to directly suppress basal type 5 adenylyl cyclase activity and attenuate Gβγ stimulation of AC5, revealing a GAP-independent effector-level mechanism for cAMP regulation in striatal neurons.","evidence":"Co-immunoprecipitation, AC5 activity assay, RGS9 knockout mice with cAMP measurements","pmids":["22932702"],"confidence":"High","gaps":["Whether direct AC5 suppression requires Gβ5 or is RGS9-2-autonomous unclear","Structural basis of AC5 interaction not determined"]},{"year":2018,"claim":"RGS9-2 ablation in D2-MSNs was shown to reduce NMDAR calcium influx and inhibit retrograde endocannabinoid signaling, revealing a role for RGS9-2 in synaptic plasticity at a specific cell-type level.","evidence":"Electrophysiology in identified D1- vs D2-MSNs, calcium imaging, pharmacological dissection","pmids":["30006367"],"confidence":"High","gaps":["Which Gα subunit mediates the NMDAR–endocannabinoid link not identified","Whether this mechanism operates in non-striatal neurons unknown"]},{"year":2019,"claim":"RGS9-2 was found to stabilize D2 receptor surface expression by competing with β-arrestin2, preventing D2R lysosomal degradation; this mechanism is disrupted in DYT1 dystonia and rescuable by RGS9-2 overexpression.","evidence":"Co-immunoprecipitation, lentiviral overexpression/knockdown, lysosomal inhibitor experiments, electrophysiology in Dyt1 striatal neurons","pmids":["30552094"],"confidence":"High","gaps":["Structural basis of RGS9-2/β-arrestin2 competition at D2R unknown","Whether this receptor-stabilizing role extends to other GPCRs untested","Therapeutic potential of RGS9-2 in dystonia not validated in vivo"]},{"year":null,"claim":"Key unresolved questions include: the structural basis of R9AP/R7BP-mediated catalytic potentiation, whether RGS9-2 nuclear translocation has a defined transcriptional function, the identity of specific cysteine proteases degrading RGS9-2, and how agonist-selective Gα complex formation (e.g., morphine-specific Gαi3 vs. Gαq) translates to distinct signaling outcomes.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structure of the full RGS9·Gβ5·R9AP or R7BP tripartite complex","Nuclear function of RGS9-2 rests on reporter assay in a single study","Agonist-biased Gα complex formation mechanism unexplored"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,4,5,14,18,21,35,41]},{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[0,5,21]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[10,13,30]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[39]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[27]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,3,18,22,23,26,41,43]},{"term_id":"R-HSA-9709957","term_label":"Sensory Perception","supporting_discovery_ids":[0,5,9,25]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[18,22,26,43]}],"complexes":["RGS9-1·Gβ5L·R9AP","RGS9-2·Gβ5·R7BP"],"partners":["GNB5","RGS9BP","RSBP","GNAI1","GNAT1","ADCY5","ARRB2","HSPA8"],"other_free_text":[]},"mechanistic_narrative":"RGS9 encodes two tissue-specific splice isoforms—RGS9-1 in photoreceptors and RGS9-2 in striatal neurons—that function as GTPase-accelerating proteins (GAPs) for Gα subunits within obligate heterodimeric complexes with Gβ5, thereby terminating G-protein signaling cascades critical for vision, dopaminergic neurotransmission, and opioid responsiveness [PMID:9459445, PMID:10051575, PMID:12818179, PMID:14595021]. In photoreceptors, the RGS9-1·Gβ5L complex is anchored to disk membranes by R9AP via the DEP domain, which enhances catalytic activity up to ~70-fold and is required for proteolytic stability; PDE6γ further potentiates GAP activity toward transducin, and loss-of-function mutations in RGS9 or R9AP cause bradyopsia in humans [PMID:12006596, PMID:14625292, PMID:14702087]. In striatal neurons, R7BP palmitoylation targets RGS9-2·Gβ5 to postsynaptic densities where it selectively terminates D2 dopamine and mu-opioid receptor signaling, directly suppresses type 5 adenylyl cyclase activity, and modulates NMDAR-dependent retrograde endocannabinoid signaling in D2-MSNs [PMID:16574655, PMID:22932702, PMID:30006367]. RGS9-2 additionally controls D2 receptor surface levels by competing with β-arrestin2 for receptor-associated interactions, preventing lysosomal D2R degradation, while its own stability is governed by R7BP shielding from Hsc70-mediated lysosomal cysteine protease degradation [PMID:30552094, PMID:18094251, PMID:20095651]."},"prefetch_data":{"uniprot":{"accession":"O75916","full_name":"Regulator of G-protein signaling 9","aliases":[],"length_aa":674,"mass_kda":77.0,"function":"Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits thereby driving them into their inactive GDP-bound form. Binds to GNAT1. Involved in phototransduction; key element in the recovery phase of visual transduction (By similarity)","subcellular_location":"Membrane","url":"https://www.uniprot.org/uniprotkb/O75916/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RGS9","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RGS9","total_profiled":1310},"omim":[{"mim_id":"620344","title":"PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION 2; PERRS2","url":"https://www.omim.org/entry/620344"},{"mim_id":"610890","title":"REGULATOR OF G PROTEIN SIGNALING 7-BINDING PROTEIN; RGS7BP","url":"https://www.omim.org/entry/610890"},{"mim_id":"608415","title":"PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION 1; PERRS1","url":"https://www.omim.org/entry/608415"},{"mim_id":"607814","title":"REGULATOR OF G PROTEIN SIGNALING 9-BINDING PROTEIN; RGS9BP","url":"https://www.omim.org/entry/607814"},{"mim_id":"604447","title":"GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-5; GNB5","url":"https://www.omim.org/entry/604447"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Nucleoplasm","reliability":"Uncertain"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":62.9}],"url":"https://www.proteinatlas.org/search/RGS9"},"hgnc":{"alias_symbol":["PERRS","RGS9L","MGC26458","MGC111763"],"prev_symbol":[]},"alphafold":{"accession":"O75916","domains":[{"cath_id":"1.10.167.10","chopping":"268-426","consensus_level":"medium","plddt":96.6813,"start":268,"end":426}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O75916","model_url":"https://alphafold.ebi.ac.uk/files/AF-O75916-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O75916-F1-predicted_aligned_error_v6.png","plddt_mean":73.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RGS9","jax_strain_url":"https://www.jax.org/strain/search?query=RGS9"},"sequence":{"accession":"O75916","fasta_url":"https://rest.uniprot.org/uniprotkb/O75916.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O75916/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O75916"}},"corpus_meta":[{"pmid":"10676965","id":"PMC_10676965","title":"Slowed recovery of rod photoresponse in mice lacking the GTPase accelerating protein RGS9-1.","date":"2000","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10676965","citation_count":375,"is_preprint":false},{"pmid":"9459445","id":"PMC_9459445","title":"RGS9, a GTPase accelerator for phototransduction.","date":"1998","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/9459445","citation_count":295,"is_preprint":false},{"pmid":"12818179","id":"PMC_12818179","title":"RGS9 modulates dopamine signaling in the basal ganglia.","date":"2003","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/12818179","citation_count":215,"is_preprint":false},{"pmid":"14595021","id":"PMC_14595021","title":"Essential role for RGS9 in opiate action.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/14595021","citation_count":203,"is_preprint":false},{"pmid":"10051575","id":"PMC_10051575","title":"The GTPase activating factor for transducin in rod photoreceptors is the complex between RGS9 and type 5 G protein beta subunit.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10051575","citation_count":185,"is_preprint":false},{"pmid":"15728856","id":"PMC_15728856","title":"D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways.","date":"2005","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15728856","citation_count":144,"is_preprint":false},{"pmid":"10066255","id":"PMC_10066255","title":"Cloning and characterization of RGS9-2: a striatal-enriched alternatively spliced product of the RGS9 gene.","date":"1999","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10066255","citation_count":135,"is_preprint":false},{"pmid":"14702087","id":"PMC_14702087","title":"Defects in RGS9 or its anchor protein R9AP in patients with slow photoreceptor deactivation.","date":"2004","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/14702087","citation_count":133,"is_preprint":false},{"pmid":"12119397","id":"PMC_12119397","title":"R9AP, a membrane anchor for the photoreceptor GTPase accelerating protein, RGS9-1.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12119397","citation_count":132,"is_preprint":false},{"pmid":"10840031","id":"PMC_10840031","title":"Complexes of the G protein subunit gbeta 5 with the regulators of G protein signaling RGS7 and RGS9. Characterization in native tissues and in transfected cells.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10840031","citation_count":131,"is_preprint":false},{"pmid":"12531899","id":"PMC_12531899","title":"RGS6, RGS7, RGS9, and RGS11 stimulate GTPase activity of Gi family G-proteins with differential selectivity and maximal activity.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12531899","citation_count":126,"is_preprint":false},{"pmid":"14614075","id":"PMC_14614075","title":"The DEP domain determines subcellular targeting of the GTPase activating protein RGS9 in vivo.","date":"2003","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/14614075","citation_count":99,"is_preprint":false},{"pmid":"11720701","id":"PMC_11720701","title":"Elevated levels of DeltaFosB and RGS9 in striatum in Parkinson's disease.","date":"2001","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/11720701","citation_count":94,"is_preprint":false},{"pmid":"11882295","id":"PMC_11882295","title":"Signal-dependent translocation of transducin, RGS9-1-Gbeta5L complex, and arrestin to detergent-resistant membrane rafts in photoreceptors.","date":"2002","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/11882295","citation_count":94,"is_preprint":false},{"pmid":"18160641","id":"PMC_18160641","title":"RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease.","date":"2007","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18160641","citation_count":94,"is_preprint":false},{"pmid":"18204463","id":"PMC_18204463","title":"Crystal structure of the multifunctional Gbeta5-RGS9 complex.","date":"2008","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18204463","citation_count":90,"is_preprint":false},{"pmid":"15534226","id":"PMC_15534226","title":"RGS9-2 modulates D2 dopamine receptor-mediated Ca2+ channel inhibition in rat striatal cholinergic interneurons.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15534226","citation_count":83,"is_preprint":false},{"pmid":"14625292","id":"PMC_14625292","title":"Absence of the RGS9.Gbeta5 GTPase-activating complex in photoreceptors of the R9AP knockout mouse.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14625292","citation_count":76,"is_preprint":false},{"pmid":"9556034","id":"PMC_9556034","title":"RGS9: a regulator of G-protein signalling with specific expression in rat and mouse striatum.","date":"1998","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/9556034","citation_count":75,"is_preprint":false},{"pmid":"10978345","id":"PMC_10978345","title":"Modules in the photoreceptor RGS9-1.Gbeta 5L GTPase-accelerating protein complex control effector coupling, GTPase acceleration, protein folding, and stability.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10978345","citation_count":74,"is_preprint":false},{"pmid":"11262419","id":"PMC_11262419","title":"RGS9-1 is required for normal inactivation of mouse cone phototransduction.","date":"2001","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/11262419","citation_count":72,"is_preprint":false},{"pmid":"11207815","id":"PMC_11207815","title":"RGS9 proteins facilitate acute tolerance to mu-opioid effects.","date":"2001","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11207815","citation_count":71,"is_preprint":false},{"pmid":"15632124","id":"PMC_15632124","title":"Activation of mu-opioid receptors transfers control of Galpha subunits to the regulator of G-protein signaling RGS9-2: role in receptor desensitization.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15632124","citation_count":65,"is_preprint":false},{"pmid":"21490202","id":"PMC_21490202","title":"A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia.","date":"2011","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21490202","citation_count":58,"is_preprint":false},{"pmid":"10564809","id":"PMC_10564809","title":"Structure, alternative splicing, and expression of the human RGS9 gene.","date":"1999","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10564809","citation_count":58,"is_preprint":false},{"pmid":"12560335","id":"PMC_12560335","title":"Activation of RGS9-1GTPase acceleration by its membrane anchor, R9AP.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12560335","citation_count":57,"is_preprint":false},{"pmid":"17318883","id":"PMC_17318883","title":"Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine-treated animal model of schizophrenia and in postmortem schizophrenia brain.","date":"2007","source":"Synapse (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/17318883","citation_count":56,"is_preprint":false},{"pmid":"18094251","id":"PMC_18094251","title":"Expression and localization of RGS9-2/G 5/R7BP complex in vivo is set by dynamic control of its constitutive degradation by cellular cysteine proteases.","date":"2007","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18094251","citation_count":55,"is_preprint":false},{"pmid":"12006596","id":"PMC_12006596","title":"Specific binding of RGS9-Gbeta 5L to protein anchor in photoreceptor membranes greatly enhances its catalytic activity.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12006596","citation_count":55,"is_preprint":false},{"pmid":"17725581","id":"PMC_17725581","title":"RGS9-2 is a negative modulator of mu-opioid receptor function.","date":"2007","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17725581","citation_count":54,"is_preprint":false},{"pmid":"11495924","id":"PMC_11495924","title":"RGS9-G beta 5 substrate selectivity in photoreceptors. Opposing effects of constituent domains yield high affinity of RGS interaction with the G protein-effector complex.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11495924","citation_count":53,"is_preprint":false},{"pmid":"17158100","id":"PMC_17158100","title":"The membrane anchor R7BP controls the proteolytic stability of the striatal specific RGS protein, RGS9-2.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17158100","citation_count":53,"is_preprint":false},{"pmid":"16574655","id":"PMC_16574655","title":"Subcellular targeting of RGS9-2 is controlled by multiple molecular determinants on its membrane anchor, R7BP.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16574655","citation_count":53,"is_preprint":false},{"pmid":"17493623","id":"PMC_17493623","title":"Evidence for the involvement of ERbeta and RGS9-2 in 17-beta estradiol enhancement of amphetamine-induced place preference behavior.","date":"2007","source":"Hormones and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/17493623","citation_count":47,"is_preprint":false},{"pmid":"30552094","id":"PMC_30552094","title":"RGS9-2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse models.","date":"2019","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30552094","citation_count":44,"is_preprint":false},{"pmid":"20477943","id":"PMC_20477943","title":"RGS9-2 mediates specific inhibition of agonist-induced internalization of D2-dopamine receptors.","date":"2010","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20477943","citation_count":41,"is_preprint":false},{"pmid":"19751658","id":"PMC_19751658","title":"RGS9 concentration matters in rod phototransduction.","date":"2009","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/19751658","citation_count":40,"is_preprint":false},{"pmid":"18073128","id":"PMC_18073128","title":"Motor coordination deficits in mice lacking RGS9.","date":"2007","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/18073128","citation_count":39,"is_preprint":false},{"pmid":"20043004","id":"PMC_20043004","title":"R7BP complexes with RGS9-2 and RGS7 in the striatum differentially control motor learning and locomotor responses to cocaine.","date":"2009","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20043004","citation_count":38,"is_preprint":false},{"pmid":"11601986","id":"PMC_11601986","title":"Phosphorylation of the regulator of G protein signaling RGS9-1 by protein kinase A is a potential mechanism of light- and Ca2+-mediated regulation of G protein function in photoreceptors.","date":"2001","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11601986","citation_count":37,"is_preprint":false},{"pmid":"19211160","id":"PMC_19211160","title":"RGS9-2: probing an intracellular modulator of behavior as a drug target.","date":"2009","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/19211160","citation_count":37,"is_preprint":false},{"pmid":"11008492","id":"PMC_11008492","title":"RGS proteins: lessons from the RGS9 subfamily.","date":"2001","source":"Progress in nucleic acid research and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11008492","citation_count":36,"is_preprint":false},{"pmid":"11292825","id":"PMC_11292825","title":"Phosphorylation of RGS9-1 by an endogenous protein kinase in rod outer segments.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11292825","citation_count":36,"is_preprint":false},{"pmid":"26305935","id":"PMC_26305935","title":"RGS9-2--controlled adaptations in the striatum determine the onset of action and efficacy of antidepressants in neuropathic pain states.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26305935","citation_count":36,"is_preprint":false},{"pmid":"22932702","id":"PMC_22932702","title":"The complex of G protein regulator RGS9-2 and Gβ(5) controls sensitization and signaling kinetics of type 5 adenylyl cyclase in the striatum.","date":"2012","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/22932702","citation_count":36,"is_preprint":false},{"pmid":"24561386","id":"PMC_24561386","title":"Nucleus accumbens-specific interventions in RGS9-2 activity modulate responses to morphine.","date":"2014","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24561386","citation_count":34,"is_preprint":false},{"pmid":"36122241","id":"PMC_36122241","title":"Human cone elongation responses can be explained by photoactivated cone opsin and membrane swelling and osmotic response to phosphate produced by RGS9-catalyzed GTPase.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/36122241","citation_count":30,"is_preprint":false},{"pmid":"19818506","id":"PMC_19818506","title":"Novel mutations and electrophysiologic findings in RGS9- and R9AP-associated retinal dysfunction (Bradyopsia).","date":"2009","source":"Ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/19818506","citation_count":29,"is_preprint":false},{"pmid":"22006018","id":"PMC_22006018","title":"β-arrestin2 plays permissive roles in the inhibitory activities of RGS9-2 on G protein-coupled receptors by maintaining RGS9-2 in the open conformation.","date":"2011","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22006018","citation_count":28,"is_preprint":false},{"pmid":"9712827","id":"PMC_9712827","title":"A possible role of RGS9 in phototransduction. A bridge between the cGMP-phosphodiesterase system and the guanylyl cyclase system.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9712827","citation_count":27,"is_preprint":false},{"pmid":"10213594","id":"PMC_10213594","title":"Modulation of transducin GTPase activity by chimeric RGS16 and RGS9 regulators of G protein signaling and the effector molecule.","date":"1999","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10213594","citation_count":27,"is_preprint":false},{"pmid":"15110994","id":"PMC_15110994","title":"Brain-specific RGS9-2 is localized to the nucleus via its unique proline-rich domain.","date":"2004","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/15110994","citation_count":26,"is_preprint":false},{"pmid":"14664818","id":"PMC_14664818","title":"Expression patterns of the RGS9-1 anchoring protein R9AP in the chicken and mouse suggest multiple roles in the nervous system.","date":"2003","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/14664818","citation_count":26,"is_preprint":false},{"pmid":"28074831","id":"PMC_28074831","title":"RGS9-2 Modulates Responses to Oxycodone in Pain-Free and Chronic Pain States.","date":"2017","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28074831","citation_count":25,"is_preprint":false},{"pmid":"17970732","id":"PMC_17970732","title":"Ontogenetic quinpirole treatment produces long-lasting decreases in the expression of Rgs9, but increases Rgs17 in the striatum, nucleus accumbens and frontal cortex.","date":"2007","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17970732","citation_count":25,"is_preprint":false},{"pmid":"16939221","id":"PMC_16939221","title":"Kinetic mechanism of RGS9-1 potentiation by R9AP.","date":"2006","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16939221","citation_count":25,"is_preprint":false},{"pmid":"25150149","id":"PMC_25150149","title":"RGS9-2 modulates sensory and mood related symptoms of neuropathic pain.","date":"2014","source":"Neurobiology of learning and memory","url":"https://pubmed.ncbi.nlm.nih.gov/25150149","citation_count":23,"is_preprint":false},{"pmid":"19098104","id":"PMC_19098104","title":"Functional comparison of RGS9 splice isoforms in a living cell.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19098104","citation_count":23,"is_preprint":false},{"pmid":"12499365","id":"PMC_12499365","title":"Identification of protein kinase C isozymes responsible for the phosphorylation of photoreceptor-specific RGS9-1 at Ser475.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12499365","citation_count":23,"is_preprint":false},{"pmid":"21511947","id":"PMC_21511947","title":"Type 5 G protein beta subunit (Gbeta5) controls the interaction of regulator of G protein signaling 9 (RGS9) with membrane anchors.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21511947","citation_count":23,"is_preprint":false},{"pmid":"15617734","id":"PMC_15617734","title":"RGS-Rz and RGS9-2 proteins control mu-opioid receptor desensitisation in CNS: the role of activated Galphaz subunits.","date":"2005","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15617734","citation_count":23,"is_preprint":false},{"pmid":"20374717","id":"PMC_20374717","title":"Biology and functions of the RGS9 isoforms.","date":"2009","source":"Progress in molecular biology and translational science","url":"https://pubmed.ncbi.nlm.nih.gov/20374717","citation_count":20,"is_preprint":false},{"pmid":"18548510","id":"PMC_18548510","title":"Analysis of genetic variations in the RGS9 gene and antipsychotic-induced tardive dyskinesia in schizophrenia.","date":"2009","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18548510","citation_count":20,"is_preprint":false},{"pmid":"12093815","id":"PMC_12093815","title":"Noncatalytic domains of RGS9-1.Gbeta 5L play a decisive role in establishing its substrate specificity.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12093815","citation_count":20,"is_preprint":false},{"pmid":"17936734","id":"PMC_17936734","title":"MPTP administration in mice changes the ratio of splice isoforms of fosB and rgs9.","date":"2007","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/17936734","citation_count":18,"is_preprint":false},{"pmid":"24327964","id":"PMC_24327964","title":"Ablation of TrkB expression in RGS9-2 cells leads to hyperphagic obesity.","date":"2013","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24327964","citation_count":18,"is_preprint":false},{"pmid":"15065220","id":"PMC_15065220","title":"Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.","date":"2004","source":"Synapse (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/15065220","citation_count":18,"is_preprint":false},{"pmid":"18318613","id":"PMC_18318613","title":"The loss of the PDE6 deactivating enzyme, RGS9, results in precocious light adaptation at low light levels.","date":"2008","source":"Journal of vision","url":"https://pubmed.ncbi.nlm.nih.gov/18318613","citation_count":17,"is_preprint":false},{"pmid":"22665478","id":"PMC_22665478","title":"Functional mapping of interacting regions of the photoreceptor phosphodiesterase (PDE6) γ-subunit with PDE6 catalytic dimer, transducin, and regulator of G-protein signaling9-1 (RGS9-1).","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22665478","citation_count":16,"is_preprint":false},{"pmid":"28302678","id":"PMC_28302678","title":"Bright flash response recovery of mammalian rods in vivo is rate limited by RGS9.","date":"2017","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/28302678","citation_count":16,"is_preprint":false},{"pmid":"19912469","id":"PMC_19912469","title":"Distribution of RGS9-2 in neurons of the mouse striatum.","date":"2009","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19912469","citation_count":15,"is_preprint":false},{"pmid":"21741448","id":"PMC_21741448","title":"RGS9-2 modulates nociceptive behaviour and opioid-mediated synaptic transmission in the spinal dorsal horn.","date":"2011","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/21741448","citation_count":13,"is_preprint":false},{"pmid":"15488179","id":"PMC_15488179","title":"Kinetic approaches to study the function of RGS9 isoforms.","date":"2004","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/15488179","citation_count":13,"is_preprint":false},{"pmid":"16153714","id":"PMC_16153714","title":"Differential expression of the regulator of G protein signaling RGS9 protein in nociceptive pathways of different age rats.","date":"2005","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/16153714","citation_count":13,"is_preprint":false},{"pmid":"23555598","id":"PMC_23555598","title":"Light-induced translocation of RGS9-1 and Gβ5L in mouse rod photoreceptors.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23555598","citation_count":12,"is_preprint":false},{"pmid":"11677233","id":"PMC_11677233","title":"Dependence of RGS9-1 membrane attachment on its C-terminal tail.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11677233","citation_count":12,"is_preprint":false},{"pmid":"20095651","id":"PMC_20095651","title":"Proteomic identification of Hsc70 as a mediator of RGS9-2 degradation by in vivo interactome analysis.","date":"2010","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/20095651","citation_count":12,"is_preprint":false},{"pmid":"15640770","id":"PMC_15640770","title":"Estrogen modulates RGS9 expression in the nucleus accumbens.","date":"2004","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/15640770","citation_count":11,"is_preprint":false},{"pmid":"25455864","id":"PMC_25455864","title":"Effects of gender on locomotor sensitivity to amphetamine, body weight, and fat mass in regulator of G protein signaling 9 (RGS9) knockout mice.","date":"2014","source":"Physiology & behavior","url":"https://pubmed.ncbi.nlm.nih.gov/25455864","citation_count":10,"is_preprint":false},{"pmid":"11485301","id":"PMC_11485301","title":"Inhibition of retinal guanylyl cyclase by the RGS9-1 N-terminus.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11485301","citation_count":10,"is_preprint":false},{"pmid":"20943919","id":"PMC_20943919","title":"Membrane anchoring subunits specify selective regulation of RGS9·Gbeta5 GAP complex in photoreceptor neurons.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20943919","citation_count":9,"is_preprint":false},{"pmid":"15488178","id":"PMC_15488178","title":"Characterization of R9AP, a membrane anchor for the photoreceptor GTPase-accelerating protein, RGS9-1.","date":"2004","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/15488178","citation_count":8,"is_preprint":false},{"pmid":"22096596","id":"PMC_22096596","title":"RGS9 knockout causes a short delay in light responses of ON-bipolar cells.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22096596","citation_count":7,"is_preprint":false},{"pmid":"30006367","id":"PMC_30006367","title":"Selective Role of RGS9-2 in Regulating Retrograde Synaptic Signaling of Indirect Pathway Medium Spiny Neurons in Dorsal Striatum.","date":"2018","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30006367","citation_count":6,"is_preprint":false},{"pmid":"12596919","id":"PMC_12596919","title":"RGS9-1 phosphorylation and Ca2+.","date":"2002","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/12596919","citation_count":5,"is_preprint":false},{"pmid":"15474482","id":"PMC_15474482","title":"Enhancement of pheromone response by RGS9 and Gbeta5 in yeast.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15474482","citation_count":5,"is_preprint":false},{"pmid":"20561938","id":"PMC_20561938","title":"Decreased RGS9 protein level in the striatum of rodents undergoing MPTP or 6-OHDA neurotoxicity.","date":"2010","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/20561938","citation_count":4,"is_preprint":false},{"pmid":"21616123","id":"PMC_21616123","title":"Regulator of G protein signaling 9-2 (RGS9-2) mRNA is up regulated during neuronal differentiation of mouse embryonic stem cells.","date":"2011","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/21616123","citation_count":4,"is_preprint":false},{"pmid":"21963945","id":"PMC_21963945","title":"The involvement of RGS9 in l-3,4-dihydroxyphenylalanine-induced dyskinesias in unilateral 6-OHDA lesion rat model.","date":"2011","source":"Brain research bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/21963945","citation_count":4,"is_preprint":false},{"pmid":"24663062","id":"PMC_24663062","title":"Adaptive gene regulation in the Striatum of RGS9-deficient mice.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24663062","citation_count":3,"is_preprint":false},{"pmid":"22569849","id":"PMC_22569849","title":"The 5-HT1A-receptor agonist flibanserin reduces drug-induced dyskinesia in RGS9-deficient mice.","date":"2012","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/22569849","citation_count":3,"is_preprint":false},{"pmid":"15901556","id":"PMC_15901556","title":"[Analysis of GUCA1B,GNGT1 and RGS9 genes in patients with retinitis pigmentosa].","date":"2002","source":"Yi chuan = Hereditas","url":"https://pubmed.ncbi.nlm.nih.gov/15901556","citation_count":3,"is_preprint":false},{"pmid":"40955044","id":"PMC_40955044","title":"Multimodal imaging and electrophysiological features in bradyopsia associated with homozygous variants (c.895T>C) in Regulator of G-protein Signaling 9 (RGS9).","date":"2025","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/40955044","citation_count":0,"is_preprint":false},{"pmid":"33453187","id":"PMC_33453187","title":"Structural information and membrane binding of truncated RGS9-1 Anchor Protein and its C-terminal hydrophobic segment.","date":"2021","source":"Biochimica et biophysica acta. Biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/33453187","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45377,"output_tokens":10071,"usd":0.143598},"stage2":{"model":"claude-opus-4-6","input_tokens":14239,"output_tokens":4027,"usd":0.257805},"total_usd":0.401403,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"RGS9 was identified as the GTPase-accelerating protein (GAP) for the visual G protein transducin (Gαt) in rod outer segments; its RGS domain accelerates GTP hydrolysis by Gαt, and this activity is enhanced by the PDEγ subunit of cGMP phosphodiesterase.\",\n      \"method\": \"In vitro GTPase assay, mRNA expression analysis, protein colocalization to photoreceptor outer segments\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro GAP activity, multiple orthogonal methods, foundational paper with >295 citations\",\n      \"pmids\": [\"9459445\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"RGS9 directly interacts with retinal guanylyl cyclase (retGC) and inhibits its activity, suggesting RGS9 mediates a direct link between the cGMP-phosphodiesterase and guanylyl cyclase systems in phototransduction.\",\n      \"method\": \"2D gel electrophoresis, antibody binding assay, immunoprecipitation, in vitro GC activity assay, peptide sequencing\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct interaction shown by IP and overlay, single lab with multiple methods\",\n      \"pmids\": [\"9712827\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Functionally active RGS9 in vertebrate photoreceptors exists as a tight complex with the long splice variant of Gβ5 (Gβ5L); this complex forms when RGS9 and Gβ5L are co-expressed in cell culture, and the GGL domain of RGS9 mediates the Gβ5 interaction.\",\n      \"method\": \"Co-purification from native photoreceptors, co-expression in cell culture, biochemical characterization\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — native complex purification plus cell culture reconstitution, replicated across labs\",\n      \"pmids\": [\"10051575\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"RGS9-2, a striatum-specific splice isoform of RGS9 with a unique 191-amino-acid C-terminal extension, dampens Gi/o-coupled mu-opioid receptor response in vitro, while the retinal isoform RGS9-1 does not.\",\n      \"method\": \"Cloning from forebrain cDNA library, in vitro functional assay with mu-opioid receptor, immunohistochemistry\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional isoform comparison with direct in vitro assay, independent characterization\",\n      \"pmids\": [\"10066255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The PDEγ C-terminal domain (residues 63–87) potentiates RGS9 GAP activity toward Gαt; chimeric RGS9/RGS16 analysis mapped the structural determinants to the α3–α5 region of the RGS9 domain, which faces the PDEγ binding site on Gαt.\",\n      \"method\": \"In vitro GTPase assay, chimeric protein mutagenesis, structure-function analysis\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro with mutagenesis, mechanistic domain mapping\",\n      \"pmids\": [\"10213594\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"RGS9-1 knockout mice lack functional Gβ5L protein (despite normal mRNA) and exhibit severely slowed GTP hydrolysis in rod outer segment membranes and dramatically prolonged photoresponse recovery, establishing RGS9-1/Gβ5L as essential for transducin GTPase acceleration in vivo.\",\n      \"method\": \"Mouse knockout, ROS GTPase assay, electrophysiology (single-cell recordings), Western blot\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — knockout mouse with in vitro GTPase assay and electrophysiology, replicated and foundational\",\n      \"pmids\": [\"10676965\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Gβ5L stabilizes RGS9-1 protein and is required for its folding and GAP activity; the GGL-Gβ5 complex modulates GAP activity in response to PDEγ; the C-terminal domain of RGS9-1 contributes to effector stimulation. Native Gβ5 and R7-family RGS proteins exist exclusively as obligate heterodimers in cells, maintained by mutual protein stabilization (non-transcriptional mechanism).\",\n      \"method\": \"In vitro reconstitution, domain deletion mutagenesis, transgenic Xenopus, co-purification, immunoprecipitation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with mutagenesis, confirmed in vivo in transgenic Xenopus\",\n      \"pmids\": [\"10978345\", \"10840031\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"RGS9-1 is phosphorylated by an endogenous protein kinase at Ser475 in rod outer segments in a light- and Ca2+-dependent manner; phosphorylation at this site reduces RGS9-1 GAP activity, identified as a potential mechanism for light-adaptation feedback on phototransduction.\",\n      \"method\": \"32P-ATP labeling, mass spectrometry, site-directed mutagenesis (S475A), in vitro kinase assay, immunoblot of dark- vs. light-adapted retina\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — phosphosite identified by MS, mutagenesis confirmed, activity assay, in vivo light-regulation shown\",\n      \"pmids\": [\"11292825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"PKA is the major kinase responsible for RGS9-1 phosphorylation in rod outer segments; phosphorylation sites mapped to Ser427 and Ser428; phosphomimetic substitution (Ser→Glu) reduces GAP activity.\",\n      \"method\": \"Kinase inhibitor panel, dibutyryl-cAMP stimulation, recombinant PKA phosphorylation, mutagenesis, in vitro GAP assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro phosphorylation with mutagenesis and functional readout\",\n      \"pmids\": [\"11601986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"RGS9-1 is required for normal inactivation of both rod and cone phototransduction; cones of RGS9-1−/− mice show ~60-fold slower recovery after bright conditioning flash.\",\n      \"method\": \"ERG in knockout mice, immunohistochemistry\",\n      \"journal\": \"Molecular vision\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knockout with defined electrophysiological phenotype replicated in cone and rod pathways\",\n      \"pmids\": [\"11262419\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The C-terminal domain of RGS9-1 (absent in RGS9-2) is critical for tight membrane binding to rod outer segment disk membranes; Gβ5L does not itself play an important role in membrane attachment.\",\n      \"method\": \"Limited proteolysis, recombinant domain constructs, membrane binding assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — domain deletion with direct membrane binding quantification\",\n      \"pmids\": [\"11677233\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Gβ5 and R7-family RGS proteins (including RGS9) always co-exist as obligate heterodimers in native tissue; Gβ5 co-expression dramatically increases RGS protein levels via protein stabilization, not transcriptional effects.\",\n      \"method\": \"Immunoprecipitation, conventional chromatography, co-expression in COS-7 cells, Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple biochemical approaches across native tissue and cell lines\",\n      \"pmids\": [\"10840031\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Noncatalytic domains of RGS9-1·Gβ5 play a decisive role in establishing substrate specificity for transducin bound to its effector (PDE) rather than free transducin; double L353E/R360P mutation reversed specificity of the catalytic domain alone but not of the full complex.\",\n      \"method\": \"Site-directed mutagenesis, single-turnover GTPase assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis with reconstituted in vitro functional assay\",\n      \"pmids\": [\"11495924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"R9AP (RGS9-1 Anchor Protein) is a 25-kDa transmembrane phosphoprotein that binds to the N-terminal domain of RGS9-1 via its DEP domain and anchors RGS9-1·Gβ5 to photoreceptor disk membranes via a C-terminal transmembrane helix; R9AP is expressed exclusively in photoreceptors.\",\n      \"method\": \"Co-immunoprecipitation from detergent extracts, cDNA cloning, immunohistochemistry, domain binding assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — co-IP of endogenous complex plus domain mapping, replicated\",\n      \"pmids\": [\"12119397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Specific binding of RGS9-1·Gβ5L to R9AP-containing photoreceptor membranes (via the DEP domain) produces an ~70-fold increase in RGS9-1 catalytic activity toward transducin GTPase; membrane association is DEP-domain dependent.\",\n      \"method\": \"Urea extraction, recombinant protein binding to native membranes, in vitro GTPase assay, domain deletion constructs\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted membrane binding with domain mutagenesis and enzymatic assay\",\n      \"pmids\": [\"12006596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Light exposure triggers translocation of the RGS9-1·Gβ5L complex (along with transducin) to detergent-resistant membrane rafts; this translocation requires Gαt activation (blocked by GTPγS or pertussis toxin, mimicked by AlF4−); phosphorylation of RGS9-1 occurs exclusively within rafts.\",\n      \"method\": \"Detergent-resistant membrane fractionation, light/dark adaptation experiments, pharmacological manipulation of G-protein state\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple pharmacological controls demonstrating G-protein state dependence, single lab\",\n      \"pmids\": [\"11882295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"PKCα and PKCθ are the major kinases responsible for RGS9-1 phosphorylation at Ser475 in rod outer segments; phosphorylation is removed by protein phosphatase 2A; PKC-mediated phosphorylation reduces RGS9-1 affinity for R9AP.\",\n      \"method\": \"Kinase purification, in vitro kinase assay with recombinant PKC isoforms, synthetic peptide substrate, protein phosphatase assay, affinity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — purification of kinase activity, reconstituted phosphorylation, functional consequence on R9AP binding\",\n      \"pmids\": [\"12499365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The N-terminus of RGS9-1 directly inhibits retinal guanylyl cyclase (retGC) activity; the GGL and RGS domains serve as internal suppressors of this inhibitory activity; direct interaction of retGC with RGS9-1 N-terminus confirmed by immunoprecipitation and overlay.\",\n      \"method\": \"Immunoprecipitation, overlay assay, in vitro retGC activity assay with RGS9-1 fragments\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding and enzymatic assay, single lab\",\n      \"pmids\": [\"11485301\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"RGS9-2 modulates dopamine D2 receptor function in striatum; viral overexpression of RGS9-2 in nucleus accumbens reduced locomotor responses to cocaine and D2 agonists; RGS9 knockout mice showed heightened locomotor and rewarding responses to cocaine; in Xenopus oocytes, RGS9-2 accelerated off-kinetics of D2R-induced GIRK currents.\",\n      \"method\": \"Viral-mediated overexpression, knockout mouse behavioral assays, Xenopus oocyte electrophysiology (GIRK currents)\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (in vivo overexpression, knockout behavior, electrophysiology), replicated across labs\",\n      \"pmids\": [\"12818179\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"R9AP knockout results in complete absence of RGS9 protein (not mRNA) from retina, establishing that R9AP determines the proteolytic stability of the RGS9·Gβ5 complex; all three proteins (RGS9, Gβ5, R9AP) are obligate members of the photoreceptor GAP complex.\",\n      \"method\": \"R9AP knockout mouse, Western blot, mRNA analysis, electrophysiology\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knockout mouse with protein/mRNA dissociation and functional readout\",\n      \"pmids\": [\"14625292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The DEP domain of RGS9 is essential for its delivery to rod outer segments; transgenic mice expressing DEP-domain-deleted RGS9 show normal expression levels but complete exclusion from outer segments; the DEP domain mediates interaction with R9AP which both targets RGS9 to outer segments and potentiates its catalytic activity.\",\n      \"method\": \"Transgenic mouse (DEP-deleted RGS9), quantitative serial tangential sectioning-Western blot, electrophysiology, domain interaction assays\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — transgenic mouse with quantitative localization and electrophysiological readout\",\n      \"pmids\": [\"14614075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Gbeta5/RGS9 and other Gbeta5/R7 dimers are selective GAPs for Gi-family Gα subunits (not Gαq or Gα11); Gbeta5/RGS9 and Gbeta5/RGS11 are more potent GAPs for Gαi1, Gαi2, and Gαi3 than Gbeta5/RGS6 or Gbeta5/RGS7.\",\n      \"method\": \"Purified Sf9-expressed proteins, steady-state GTPase assay in proteoliposomes with M1/M2 muscarinic receptors\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — purified proteins in reconstituted lipid system with quantitative kinetics\",\n      \"pmids\": [\"12531899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"RGS9-2 via its DEP domain colocalizes with D2 dopamine receptors in mammalian cells; RGS9-2 DEP domain preferentially accelerates termination of D2 receptor (not M2 muscarinic) signals in oocytes; RGS9 knockout mice develop abnormal involuntary movements when D2 signaling is activated after dopaminergic inhibition, and RGS9-2 deletion abnormally inhibits glutamate-elicited currents in striatal neurons.\",\n      \"method\": \"Colocalization in transfected mammalian cells, oocyte electrophysiology, mouse knockout, striatal neuron recordings, behavioral analysis\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods across cell, slice, and in vivo preparations\",\n      \"pmids\": [\"15728856\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"RGS9 (as RGS9-2) is essential for normal opiate action; mice lacking RGS9 show enhanced responses to acute and chronic morphine; acute morphine increases RGS9-2 in NAc while chronic exposure decreases it, showing reciprocal regulation.\",\n      \"method\": \"Knockout mouse behavioral assays (analgesia, reward, dependence/withdrawal), Western blot\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knockout with defined behavioral phenotypes across multiple paradigms\",\n      \"pmids\": [\"14595021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"R9AP binding site on RGS9-1 is in the N-terminal (DEP-containing) domain; R9AP reconstituted into lipid vesicles increases RGS9-1 GAP activity 4-fold; the DEP domain is required for high-affinity binding (Kd <10 nM) to R9AP vesicles.\",\n      \"method\": \"Recombinant protein purification, lipid vesicle reconstitution, binding affinity measurements, single-turnover GTPase assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — purified proteins, reconstituted lipid system, quantitative binding and catalytic assays\",\n      \"pmids\": [\"12560335\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Mutations in RGS9 or R9AP in humans cause bradyopsia (delayed photoreceptor deactivation with difficulty adapting to luminance changes); R9AP enhances RGS9 activity up to 70-fold and anchors it to photoreceptor membranes.\",\n      \"method\": \"Human genetic analysis (sequencing), clinical electrophysiology, phenotype characterization\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — human loss-of-function mutations with defined visual phenotype, confirmed mechanism\",\n      \"pmids\": [\"14702087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"RGS9-2 specifically modulates D2 dopamine receptor (not M2 muscarinic receptor) inhibition of Cav2.2 calcium channels in striatal cholinergic interneurons; dialysis with RGS9 constructs enhanced basal Ca2+ channel currents; the DEP-GGL domain antagonizes endogenous RGS9-2 activity.\",\n      \"method\": \"Whole-cell patch clamp in striatal neurons, intracellular dialysis with RGS9 constructs, in vitro GTPase assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct intraneuronal protein delivery with receptor-selective electrophysiological readout\",\n      \"pmids\": [\"15534226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The brain-specific unique polyproline-rich C-terminus of RGS9-2 contains sequences sufficient to target RGS9-2 to the nucleus of COS-7 cells and striatal neurons; Gβ5 further enhances nuclear localization of RGS9-2 (but not RGS9-1); nuclear RGS9-2 increases transcriptional activity of a neuronal gene construct.\",\n      \"method\": \"Immunocytochemistry, immunoblot fractionation, deletion construct transfection, reporter gene assay\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — localization by transfection with deletion constructs, single lab, transcriptional effect not fully mechanistic\",\n      \"pmids\": [\"15110994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Mu-opioid receptor (MOR) activation promotes transfer of Gα subunits from MOR to RGS9-2 complexes, followed by Ser phosphorylation of RGS9-2 and its association with 14-3-3 proteins; tolerance-inducing morphine doses stabilize Gα retention by RGS9-2; knockdown of RGS9-2 prevents this transfer and blocks tolerance.\",\n      \"method\": \"Co-immunoprecipitation from periaqueductal gray membranes, in vivo antisense knockdown, [35S]GTPγS binding, GTPase assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP plus knockdown with functional readout, single lab\",\n      \"pmids\": [\"15632124\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"R7BP controls the proteolytic stability of RGS9-2: co-expression with R7BP dramatically elevates RGS9-2 and Gβ5 protein levels by reducing constitutive proteolysis; R7BP binds RGS9 via an interface formed by the DEP domain paired with the R7H domain; lentiviral R7BP knockdown in native striatal neurons reduces RGS9-2 protein.\",\n      \"method\": \"Co-expression in cells, protein degradation kinetics, site-directed mutagenesis of binding interface, lentiviral RNAi in striatal neurons, Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods (degradation kinetics, mutagenesis, native neuron RNAi), consistent results\",\n      \"pmids\": [\"17158100\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Subcellular targeting of RGS9-2 to plasma membrane and postsynaptic densities in striatal neurons requires the C-terminal 21 amino acids of R7BP, specifically the synergistic action of a polybasic motif and palmitoylated cysteines; depalmitoylation of R7BP unmasks nuclear localization sequences enabling nuclear import.\",\n      \"method\": \"Subcellular fractionation, site-directed mutagenesis of R7BP C-terminus, live-cell imaging, postsynaptic density fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis combined with fractionation in native neurons\",\n      \"pmids\": [\"16574655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"R9AP potentiation of RGS9-1 GAP activity is a direct increase in catalytic activity (not simply enhanced G-protein binding); the N-terminal trihelical domain of R9AP contains the RGS9-1 binding site, but the entire R9AP molecule is required for potentiation.\",\n      \"method\": \"Kinetic GTPase assay, R9AP domain deletion constructs, binding assays\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mechanistic kinetic dissection with domain constructs in reconstituted system\",\n      \"pmids\": [\"16939221\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"RGS9-2 constitutive degradation is mediated by lysosomal cysteine proteases; R7BP binding to RGS9-2 shields degradation determinants and controls RGS9-2 expression at the posttranslational level; R7BP also targets RGS9-2 to postsynaptic densities in neurons.\",\n      \"method\": \"Protease inhibitor studies, co-expression with R7BP, Western blot quantification, immunohistochemistry in developing striatum\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic identification of protease class and protective partner, multiple methods\",\n      \"pmids\": [\"18094251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Striatal RGS9-2 overexpression (via viral vector) in MPTP-lesioned monkeys and 6-OHDA-lesioned rats reduces L-DOPA-induced involuntary movements without reducing anti-parkinsonian effects of L-DOPA; RGS9 knockout mice are more susceptible to L-DOPA-induced dyskinesia, establishing RGS9-2 as a negative modulator of dyskinesia.\",\n      \"method\": \"Viral vector overexpression in primates and rats, RGS9 knockout mice, behavioral scoring\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain- and loss-of-function in multiple species with defined behavioral outcomes\",\n      \"pmids\": [\"18160641\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Crystal structure of the Gβ5-RGS9 complex at 1.95 Å resolution reveals a canonical RGS domain functionally integrated within a molecular complex poised for coordination of multiple G-protein activation and deactivation steps.\",\n      \"method\": \"X-ray crystallography\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure of native functional complex\",\n      \"pmids\": [\"18204463\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"RGS9-2 can functionally replace RGS9-1 in rod photoreceptors and supports normal photoresponse recovery; RGS9-2 inactivates transducin regardless of its effector interactions (G protein-effector complex-independent), whereas RGS9-1 preferentially acts on the G protein–effector complex.\",\n      \"method\": \"Transgenic mouse replacement of RGS9-1 with RGS9-2, single-cell electrophysiology, ERG\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — functional isoform swap in living cells with electrophysiological characterization\",\n      \"pmids\": [\"19098104\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"RGS9-2 inhibits dopamine-mediated internalization of D2R specifically (not delta opioid receptor); this requires the DEP domain and GTPase-accelerating activity of RGS9-2; RGS4 does not share this specificity.\",\n      \"method\": \"Transfection of RGS9-2 and mutants in cells, receptor internalization assay, receptor-specific comparison\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — cell-based assay with domain mutants, single lab\",\n      \"pmids\": [\"20477943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Hsc70 is recruited to the intrinsically disordered C-terminal domain of RGS9-2 following its dissociation from R7BP, mediating RGS9-2 degradation; identified by quantitative in vivo interactome analysis using knockout controls.\",\n      \"method\": \"Quantitative proteomics with knockout controls, co-immunoprecipitation, Western blot\",\n      \"journal\": \"Journal of proteome research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — quantitative proteomics with matched knockouts, functional dissection of degradation pathway\",\n      \"pmids\": [\"20095651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Gβ5 is required for RGS9 to associate with membrane anchors (R7BP or R9AP); the binding interface between the N-terminal lobe of RGS9 and Gβ5 interaction surface is needed for R7BP recruitment; distinct molecular determinants in the DEP/DHEY–Gβ5 interface differentially control R7BP binding vs. proteolytic stabilization.\",\n      \"method\": \"Protein-protein interaction assays, co-localization, protein stability assays, site-directed mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic mutagenesis with multiple functional readouts\",\n      \"pmids\": [\"21511947\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"β-arrestin2 scaffolds interactions among the DEP domain of RGS9-2, Gβ5, R7BP, and D3R; β-arrestin2 competes with R7BP and Gβ5 to place RGS9-2 in an open cytosolic conformation capable of inhibiting GPCR signaling; receptor affinity for β-arrestin2 determines the selectivity of RGS9-2 for a given receptor.\",\n      \"method\": \"Co-immunoprecipitation, transfection with domain mutants, signaling assays in cells\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP with domain mutants and signaling readouts, single lab\",\n      \"pmids\": [\"22006018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RGS9-2 in striatum forms distinct Gα-containing complexes depending on the MOR agonist: morphine uniquely promotes RGS9-2/Gαi3 association; RGS9-2/Gαq complexes form with multiple MOR agonists but not morphine; repeated morphine forms RGS9-2/Gβ5/Gαq complexes associated with analgesic tolerance.\",\n      \"method\": \"Co-immunoprecipitation from striatum, pharmacological manipulation, behavioral assays\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP with multiple agonists revealing agonist-selective complex formation, single lab\",\n      \"pmids\": [\"21490202\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"RGS9-2/Gβ5 complex directly interacts with and suppresses basal activity of type 5 adenylyl cyclase (AC5); it also attenuates Gβγ stimulation of AC5 by facilitating Gαo GTPase activity; and accelerates AC5 recovery from Gαi inhibition by increasing Gαi deactivation rate. Mice lacking RGS9 show increased cAMP production and enhanced AC5 sensitization upon opioid withdrawal.\",\n      \"method\": \"Co-immunoprecipitation, AC5 activity assay, RGS9 knockout mice, cAMP measurements\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct binding plus enzymatic assay plus knockout validation, multiple mechanisms established\",\n      \"pmids\": [\"22932702\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"RGS9-1 and Gβ5L undergo light-dependent translocation from rod inner segments to outer segments; prolonged dark adaptation causes them to accumulate in inner segments while their anchor R9AP remains in outer segments; RGS9-1 is phosphorylated at S475 in the dark, and dim light exposure leads to rapid de-phosphorylation.\",\n      \"method\": \"Immunofluorescence, Western blot with phospho-specific antibody, light/dark adaptation protocol\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment with functional consequence (phosphorylation state linked to translocation), single lab\",\n      \"pmids\": [\"23555598\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"RGS9-2 ablation in D2-MSNs reduces NMDAR-mediated calcium influx, increases AMPAR/NMDAR ratio, and inhibits retrograde endocannabinoid signaling from D2-MSNs to CB1 receptors on presynaptic terminals, leading to increased mEPSC frequency and altered paired-pulse ratio; effects are selective to D2-MSNs, not D1-MSNs.\",\n      \"method\": \"Electrophysiology in identified MSN subtypes, calcium imaging, pharmacological dissection, behavioral assays with MK-801/ketamine\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific electrophysiology and pharmacological dissection revealing novel synaptic mechanism\",\n      \"pmids\": [\"30006367\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"RGS9-2 in striatum controls D2 receptor protein levels by competing with β-arrestin2 for D2R binding protein interactions, preventing lysosomal degradation of D2R; RGS9-2 depletion mimics D2R loss in DYT1 dystonia, and RGS9-2 overexpression rescues D2R levels and electrophysiological responses in Dyt1 striatal neurons.\",\n      \"method\": \"Western blot, co-immunoprecipitation, lentiviral overexpression, lysosomal inhibitor experiments, electrophysiology\",\n      \"journal\": \"EMBO molecular medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic dissection with gain- and loss-of-function plus pharmacological validation\",\n      \"pmids\": [\"30552094\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RGS9 exists as two splice isoforms (RGS9-1 in photoreceptors, RGS9-2 in striatum) that function as GTPase-accelerating proteins for Gα subunits within obligate heterodimeric complexes with Gβ5; RGS9-1·Gβ5 is anchored to photoreceptor disk membranes by R9AP (which enhances catalytic activity ~70-fold via the DEP domain interaction and is required for proteolytic stability), where it accelerates Gαt GTP hydrolysis (potentiated by PDEγ) to enable rapid photoresponse recovery, and is subject to PKC/PKA-mediated phosphorylation at Ser475 in a light/Ca2+-regulated feedback mechanism; RGS9-2·Gβ5 is targeted to the plasma membrane and postsynaptic densities of striatal neurons by palmitoylated R7BP (which also protects RGS9-2 from constitutive lysosomal cysteine protease degradation via Hsc70), where it specifically terminates D2 dopamine receptor and mu-opioid receptor signaling by deactivating Gαi/o subunits and directly suppressing type 5 adenylyl cyclase, thereby regulating locomotion, reward, opiate analgesia/tolerance, and synaptic plasticity through NMDAR-dependent retrograde endocannabinoid signaling in D2-MSNs.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"RGS9 encodes two tissue-specific splice isoforms—RGS9-1 in photoreceptors and RGS9-2 in striatal neurons—that function as GTPase-accelerating proteins (GAPs) for Gα subunits within obligate heterodimeric complexes with Gβ5, thereby terminating G-protein signaling cascades critical for vision, dopaminergic neurotransmission, and opioid responsiveness [PMID:9459445, PMID:10051575, PMID:12818179, PMID:14595021]. In photoreceptors, the RGS9-1·Gβ5L complex is anchored to disk membranes by R9AP via the DEP domain, which enhances catalytic activity up to ~70-fold and is required for proteolytic stability; PDE6γ further potentiates GAP activity toward transducin, and loss-of-function mutations in RGS9 or R9AP cause bradyopsia in humans [PMID:12006596, PMID:14625292, PMID:14702087]. In striatal neurons, R7BP palmitoylation targets RGS9-2·Gβ5 to postsynaptic densities where it selectively terminates D2 dopamine and mu-opioid receptor signaling, directly suppresses type 5 adenylyl cyclase activity, and modulates NMDAR-dependent retrograde endocannabinoid signaling in D2-MSNs [PMID:16574655, PMID:22932702, PMID:30006367]. RGS9-2 additionally controls D2 receptor surface levels by competing with β-arrestin2 for receptor-associated interactions, preventing lysosomal D2R degradation, while its own stability is governed by R7BP shielding from Hsc70-mediated lysosomal cysteine protease degradation [PMID:30552094, PMID:18094251, PMID:20095651].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Identification of RGS9 as the photoreceptor GAP for transducin resolved the long-standing question of what accelerates GTP hydrolysis on Gαt during photoresponse recovery, with PDE6γ acting as a co-factor.\",\n      \"evidence\": \"In vitro GTPase assay with purified RGS9 domain, mRNA expression in rod outer segments\",\n      \"pmids\": [\"9459445\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological requirement not yet shown in vivo\", \"Mechanism of PDE6γ potentiation structurally unresolved\", \"No information on non-retinal isoforms\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Discovery that RGS9 exists as an obligate heterodimer with Gβ5L (via the GGL domain) and that a brain-specific isoform RGS9-2 modulates mu-opioid receptor signaling established RGS9 as a multi-isoform, multi-tissue GPCR regulator.\",\n      \"evidence\": \"Co-purification from native photoreceptors, cloning of RGS9-2 from forebrain cDNA, in vitro mu-opioid receptor functional assay\",\n      \"pmids\": [\"10051575\", \"10066255\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo requirement for Gβ5 not yet demonstrated\", \"Mechanism of isoform-specific substrate selectivity unclear\", \"Striatal function of RGS9-2 not yet tested in vivo\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"RGS9-1 knockout mice proved that the RGS9-1·Gβ5L complex is essential in vivo for rapid photoresponse recovery and that Gβ5L protein stability depends entirely on RGS9-1 co-expression.\",\n      \"evidence\": \"Knockout mouse with single-cell electrophysiology and rod outer segment GTPase assay\",\n      \"pmids\": [\"10676965\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Anchoring mechanism to disk membranes unknown\", \"Contribution to cone recovery not yet quantified\", \"Regulatory mechanisms (phosphorylation, translocation) not addressed\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identification of light- and Ca²⁺-dependent phosphorylation at Ser475 (by PKC) and Ser427/428 (by PKA) that reduces GAP activity established a feedback regulatory mechanism linking phototransduction to RGS9-1 catalytic output.\",\n      \"evidence\": \"Mass spectrometry phosphosite identification, site-directed mutagenesis, recombinant kinase assays, dark/light-adapted retinal comparison\",\n      \"pmids\": [\"11292825\", \"11601986\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological impact of phosphorylation on photoresponse kinetics not tested in vivo\", \"Phosphatase identity not fully confirmed in situ\", \"Whether phosphorylation affects R9AP binding not yet known\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Discovery of R9AP as a transmembrane anchor that binds the DEP domain of RGS9-1 and enhances catalytic activity ~70-fold resolved how RGS9 is targeted to disk membranes and why membrane association is required for full GAP function.\",\n      \"evidence\": \"Co-immunoprecipitation, DEP domain binding assays, reconstitution on R9AP-containing membranes with GTPase kinetics\",\n      \"pmids\": [\"12119397\", \"12006596\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"R9AP role in protein stability not yet demonstrated\", \"Structural basis of R9AP-mediated catalytic potentiation unresolved\", \"Whether an analogous anchor exists for RGS9-2 in brain unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"PKCα/θ-mediated Ser475 phosphorylation was shown to reduce RGS9-1 affinity for R9AP and is reversed by PP2A, linking the phosphorylation feedback to the membrane-anchoring mechanism.\",\n      \"evidence\": \"Kinase purification, recombinant PKC isoform assay, phosphatase assay, R9AP affinity measurement\",\n      \"pmids\": [\"12499365\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo consequence of PKC phosphorylation on R9AP binding not tested\", \"Whether translocation from membranes occurs upon phosphorylation unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"RGS9-2 was established as a critical regulator of dopaminergic and opioid signaling in striatum: knockout mice showed enhanced cocaine reward and locomotor responses, enhanced morphine analgesia and tolerance, and dyskinesia upon D2 activation after dopamine depletion.\",\n      \"evidence\": \"Knockout mouse behavioral assays across cocaine, morphine, and L-DOPA paradigms; viral overexpression in nucleus accumbens; Xenopus oocyte electrophysiology\",\n      \"pmids\": [\"12818179\", \"14595021\", \"15728856\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-type specificity of RGS9-2 action (D1- vs D2-MSN) not resolved\", \"Downstream signaling effectors in striatum not identified\", \"Whether RGS9-2 acts via GAP activity alone or additional mechanisms unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"R9AP knockout demonstrated that R9AP is absolutely required for RGS9 protein stability (not transcription) in vivo, confirming all three proteins (RGS9, Gβ5, R9AP) as obligate subunits of the photoreceptor GAP complex.\",\n      \"evidence\": \"R9AP knockout mouse with protein vs. mRNA analysis and electrophysiology\",\n      \"pmids\": [\"14625292\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of proteolytic degradation in absence of R9AP not identified\", \"Whether R9AP controls RGS9 trafficking beyond stability unclear\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Human loss-of-function mutations in RGS9 (and R9AP) were shown to cause bradyopsia, establishing the first Mendelian disease caused by disruption of the photoreceptor GAP complex.\",\n      \"evidence\": \"Human genetic sequencing, clinical electrophysiology in affected families\",\n      \"pmids\": [\"14702087\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genotype-phenotype correlation across mutation types not established\", \"Whether heterozygous carriers have subclinical phenotypes unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"R7BP was identified as the brain-specific membrane anchor for RGS9-2, controlling both its subcellular targeting to postsynaptic densities (via palmitoylation and a polybasic motif) and proteolytic stability by shielding it from constitutive degradation.\",\n      \"evidence\": \"Co-expression studies, degradation kinetics, mutagenesis of R7BP C-terminus, lentiviral knockdown in native striatal neurons, subcellular fractionation\",\n      \"pmids\": [\"17158100\", \"16574655\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the protease pathway not yet determined\", \"Whether R7BP also modulates RGS9-2 catalytic activity (as R9AP does for RGS9-1) untested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"The constitutive degradation pathway for RGS9-2 was identified as lysosomal cysteine protease-dependent, with R7BP binding shielding degradation determinants; Hsc70 was later shown to mediate RGS9-2 delivery to the degradation pathway upon R7BP dissociation.\",\n      \"evidence\": \"Protease inhibitor studies, co-expression with R7BP, quantitative proteomics with knockout controls\",\n      \"pmids\": [\"18094251\", \"20095651\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific cysteine protease identity not determined\", \"Whether Hsc70 delivers RGS9-2 via chaperone-mediated autophagy not confirmed\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"The 1.95 Å crystal structure of the Gβ5–RGS9 complex revealed how the canonical RGS domain is integrated within a multidomain scaffold poised for coordinated G-protein regulation.\",\n      \"evidence\": \"X-ray crystallography\",\n      \"pmids\": [\"18204463\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the full tripartite complex with R9AP or R7BP not determined\", \"Structural basis of PDE6γ potentiation unresolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"RGS9-2·Gβ5 was shown to directly suppress basal type 5 adenylyl cyclase activity and attenuate Gβγ stimulation of AC5, revealing a GAP-independent effector-level mechanism for cAMP regulation in striatal neurons.\",\n      \"evidence\": \"Co-immunoprecipitation, AC5 activity assay, RGS9 knockout mice with cAMP measurements\",\n      \"pmids\": [\"22932702\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether direct AC5 suppression requires Gβ5 or is RGS9-2-autonomous unclear\", \"Structural basis of AC5 interaction not determined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"RGS9-2 ablation in D2-MSNs was shown to reduce NMDAR calcium influx and inhibit retrograde endocannabinoid signaling, revealing a role for RGS9-2 in synaptic plasticity at a specific cell-type level.\",\n      \"evidence\": \"Electrophysiology in identified D1- vs D2-MSNs, calcium imaging, pharmacological dissection\",\n      \"pmids\": [\"30006367\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which Gα subunit mediates the NMDAR–endocannabinoid link not identified\", \"Whether this mechanism operates in non-striatal neurons unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"RGS9-2 was found to stabilize D2 receptor surface expression by competing with β-arrestin2, preventing D2R lysosomal degradation; this mechanism is disrupted in DYT1 dystonia and rescuable by RGS9-2 overexpression.\",\n      \"evidence\": \"Co-immunoprecipitation, lentiviral overexpression/knockdown, lysosomal inhibitor experiments, electrophysiology in Dyt1 striatal neurons\",\n      \"pmids\": [\"30552094\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of RGS9-2/β-arrestin2 competition at D2R unknown\", \"Whether this receptor-stabilizing role extends to other GPCRs untested\", \"Therapeutic potential of RGS9-2 in dystonia not validated in vivo\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the structural basis of R9AP/R7BP-mediated catalytic potentiation, whether RGS9-2 nuclear translocation has a defined transcriptional function, the identity of specific cysteine proteases degrading RGS9-2, and how agonist-selective Gα complex formation (e.g., morphine-specific Gαi3 vs. Gαq) translates to distinct signaling outcomes.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structure of the full RGS9·Gβ5·R9AP or R7BP tripartite complex\", \"Nuclear function of RGS9-2 rests on reporter assay in a single study\", \"Agonist-biased Gα complex formation mechanism unexplored\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 4, 5, 14, 18, 21, 35, 41]},\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [0, 5, 21]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [10, 13, 30]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [39]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [27]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 3, 18, 22, 23, 26, 41, 43]},\n      {\"term_id\": \"R-HSA-9709957\", \"supporting_discovery_ids\": [0, 5, 9, 25]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [18, 22, 26, 43]}\n    ],\n    \"complexes\": [\n      \"RGS9-1·Gβ5L·R9AP\",\n      \"RGS9-2·Gβ5·R7BP\"\n    ],\n    \"partners\": [\n      \"GNB5\",\n      \"RGS9BP\",\n      \"RSBP\",\n      \"GNAI1\",\n      \"GNAT1\",\n      \"ADCY5\",\n      \"ARRB2\",\n      \"HSPA8\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}